HOME >> BIOLOGY >> NEWS
Probing the promise and perils of nanoparticles

ANN ARBOR, Mich.---For all its promise, the prospect of using nanoparticles in biomedical applications and consumer products has raised concerns about possible harmful effects of the miniscule materials. Scientists at the University of Michigan are addressing those concerns by investigating how certain kinds of nanoparticles damage cell membranes---enough to cause cell death in some cases---and how the damage can be prevented.

"If you're inventing these sorts of materials, you need to be concerned about their impact," said Mark Banaszak Holl, a U-M professor of chemistry and of macromolecular science and engineering. "We're trying to do both: make important new materials and be excited about what can be done with them, but at the same time, understand what their potential downsides might be." Banaszak Holl and graduate students Pascale Leroueil and Seungpyo Hong will discuss their research at the 229th national meeting of the American Chemical Society in San Diego March 13-17.

In collaboration with other researchers at U-M's Center for Biologic Nanotechnology, Banaszak Holl's lab has been studying nanoparticles known as dendrimers, tiny spheres whose width is ten thousands times smaller than the thickness of a human hair. Dendrimers have shown promise for precisely delivering drugs to their targets inside the body, but high concentrations of these nanoparticles can be toxic. In earlier work, U-M researchers discovered that dendrimers punch nanoscale holes in cell membranes, making the membranes more permeable. At high enough concentrations, they can completely destroy the membranes, killing cells in the process. But the damage can be prevented by engineering dendrimers in particular ways, such as modifying their surfaces to make them neutral instead of charged, the scientists found. And, added Banaszak Holl, "not only does engineering make them less harmful, but it also makes them better at what we want them to do. You don't lose anything; it's all
'"/>

Contact: Nancy Ross-Flanigan
rossflan@umich.edu
734-647-1853
University of Michigan
15-Mar-2005


Page: 1 2

Related biology news :

1. Probing biologys dark matter
2. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
3. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
4. New proteomics research promises to revolutionize biomedical discovery
5. New research holds promise for protecting cancer patients against infertility
6. New approach to pulmonary hypertension shows promise
7. Modular leukemia drug shows promise in early testing
8. Hepatitis B drug can compromise HIV treatment
9. UCF nanoparticle offers promise for treating glaucoma
10. Identification of genetic risk factor for coeliac disease promises improved treatment
11. Canadian paper innovation holds promise for improved global health safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/27/2018)... ... December 27, 2018 , ... AxioMed completed ... new Boston facility, and is now raising growth capital to ramp up demand ... share against inferior ball and socket discs. The capital raise is targeted to ...
(Date:12/22/2018)... ... 2018 , ... On Wednesday, Dec. 12, Greenberg Traurig, LLP’s ... Helen Chen, Greater China Managing Partner of L.E.K. Chen shared her insights on ... attorney David J. Dykeman , co-chair of Greenberg Traurig’s global Life ...
(Date:12/19/2018)... ... 19, 2018 , ... InTouchMD’s flagship product, Pulse , has been honored ... , PM360 is featuring the recognition in its 7th annual Innovations issue, created for ... pharmaceutical and medical device industries. , “This recognition comes at an exciting time for ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of Gene ... named by a selection committee made up of industry leaders identified by the ASGCT ... grants are mentored awards created to support ASGCT members designing transformative pilot studies in ...
(Date:1/4/2019)... ... January 04, 2019 , ... Triangle Insights Group, a ... firm. Ted will be joining the firm as a partner. , Ted ... to the pharmaceutical industry. At Triangle Insights, Ted will apply his deep expertise ...
(Date:1/4/2019)... Calif. (PRWEB) , ... January 02, 2019 , ... ... proprietary technology to detect precancer and cancer cells in blood, has been named ... Biotech , a global biotech company developing cell therapies for cancer treatment, will ...
(Date:12/20/2018)... ... 20, 2018 , ... New Year’s brings reflection and desire to improve for ... European Union (EU) on the horizon, Jim Kasic, president and CEO of Boulder iQ, ... EU Medical Device Regulation (MDR), digital health, and big data are just a few ...
Breaking Biology Technology:
Cached News: